Revised Nomenclature for Fatty Liver Disease: Cutting through the Confusion
Open Access
- 21 September 2020
- journal article
- letter
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 8 (3), 1-2
- https://doi.org/10.14218/jcth.2020.00049
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver DiseaseGastroenterology, 2020
- What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’Liver International, 2020
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology, 2020
- Obeticholic acid: towards first approval for NASHThe Lancet, 2019
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialThe Lancet, 2019
- Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniaeCell Metabolism, 2019
- Toward More Accurate Nomenclature for Fatty Liver DiseasesGastroenterology, 2019
- The Lancet–EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequitiesThe Lancet, 2018
- Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.1980